Cancer Research

Stories

Stories 121 - 134 of 134

<< Prev 1 ... 3 4 5 6 7

June 2007
- New Drug Battles Liver Cancer
  
  New York Times | Jun 4, 07 7:37 AM CDT
  
  (Newser) - An impressive clinical trial has produced what could be the first effective drug treatment for liver cancer, the New York Times reports. Nexavar, which blocks both the blood supply to the tumor and proteins that spur tumor growth, extended the lives of patients in the trial by almost three months, or 44% More »
May 2007
- Scientists ID New Breast Cancer Genes
  
  Guardian (UK) | May 28, 07 7:11 AM CDT
  
  (Newser) - Four newly discovered genes can increase a woman's chance of developing breast cancer by as much as 60%, say scientists who hail the isolation of the genes as the biggest advance in the field since 1994. The breakthrough raises hopes for more advanced treatment and even prevention of breast cancer and for better understanding of other cancers in the future. More »
- Conservatives Wield FDA Data on HPV Vaccine
  
  Wall Street Journal | May 24, 07 3:31 CDT
  
  (Newser) - A group of religious conservatives has marshalled unreleased FDA data as a weapon in the battle against Gardasil, the new cervical cancer vaccine. The data indicates health problems in women taking the vaccine, but drugmaker Merck and the FDA both insist that the negative effects are probably unrelated to the vaccine. Critics oppose legislation to require administering the vaccine in schools. More »
- Chemicals in Tap Water, French Fries May Cause Breast Cancer
  
  Los Angeles Times | May 14, 07 10:16 AM CDT
  
  (Newser) - Hundreds of common chemicals—from a substance used in French fries to one found in tap water—may cause breast cancer, a new report linking the disease to everyday products suggests. Researchers say they've found a link between cancer in animals and more than 200 common chemicals, many of which the federal government doesn't regulate. More »
- Lefty Women Die Younger
  
  Daily Telegraph (UK) | May 2, 07 12:01 CDT
  
  (Newser) - Left-handed women have a dramatically higher risk of mortality from just about every disease, a new study reported in the Telegraph shows. Dutch researchers who followed more than 12,000 women for nearly 13 years found lefties had a 40% greater chance of dying from any cause, 70% higher from cancer, and 30% higher from circulatory diseases. More »
April 2007
- Post-Chemo Memory Loss Isn't All in the Head
  
  New York Times | Apr 29, 07 8:00 AM CDT
  
  (Newser) - Docs are finally cluing in to "chemo brain," the fuzzy-headed forgetfulness following treatment that cancer survivors have long suffered—and doctors long denied. The condition, suffered by roughly 15% of breast cancer survivors, refers to a laundry list of memory-loss issues that researchers think result from high levels of toxic exposure during chemo. More »
- Embryos Screened for Cancer Risk
  
  Times (UK) | Apr 26, 07 10:57 AM CDT
  
  (Newser) - The British government is poised to OK a procedure that screens embryos for genes that greatly increase the risk—but do not necessarily cause—breast cancer. Two couples with strong family histories of the disease are expected to pioneer the technique, already approved in principle, and crank up the debate over "designer babies." More »
- Breast Cancer Decline Tied to Hormone Drop
  
  Washington Post | Apr 19, 07 9:05 AM CDT
  
  (Newser) - Researchers are linking a dramatic drop in the number of breast cancer cases to the decline in estrogen consumption by menopausal women. Women dropped hormone replacement therapy en mass after a 2002 study tied it to breast cancer risk. Other scientists argued that the decline—about 16,000 fewer new cases per year—may have other causes. More »
- Vaccine May Not Prevent Cervical Cancer
  
  Wall Street Journal | Apr 16, 07 8:43 AM CDT
  
  (Newser) - Pharma behemoth Merck is defending what it touted as a miracle cervical-cancer vaccine against charges of ineffectiveness. Merck lobbied states to mandate Gardasil for young girls—Texas and Virginia did—and got a glowing endorsement from the CDC. But new studies show that it works only to prevent sexually-transmitted HPV, a cause of cancerous cervical growths, not the cancer itself. More »
- Cheap Anticancer Drugs Are Ignored
  
  New York Times | Apr 5, 07 9:51 CDT
  
  (Newser) - Ralph Moss writes about why inexpensive cancer treatments get no research dollars. The publisher of a newsletter that covers both conventional and alternative cancer therapies, Moss blames the inability to patent already discovered and available chemicals and drugs for the situation. More »
- Docs Tell Younger Women: Avoid Mammograms
  
  Washington Post | Apr 3, 07 8:16 AM CDT
  
  (Newser) - Forty-something women should consider skipping their annual mammograms, the American College of Physicians is suggesting after a new review of research. Docs point to danger from radiation and unnecessary biopsies, surgery and chemotherapy, thanks in part to a high rate of false positives. "We don't think the evidence supports a blanket recommendation," one of the authors told the Washington Post. More »
March 2007
- FDA Panel Passes First Cancer Vaccine
  
  New York Times | Mar 30, 07 11:20 AM CDT
  
  (Newser) - A cancer drug that's the first to harness the body's immune system to destroy tumors got a thumbs-up from the FDA's advisory panel, the New York Times reports. If approved, Provenge, a prostate cancer treatment, would be the first of the "cancer vaccines"—experimental therapies that commandeer a patient's own white blood cells to fight tumors—to hit the market. More »
- New Breast Scan Beats Mammogram
  
  Daily Telegraph (UK) | Mar 27, 07 12:58 CDT
  
  (Newser) - A new type of breast scan promises to pick up the tumors mammograms often miss and to distinguish between benign and malignant masses—without surgery. The technology relies on harmless near-infrared light to illuminate the masses, which glow when exposed to a particular chemical combination. More »
January 1900
- American Cancer Society Facts and Figures (pdf download)
  
  American Cancer Society | Jan 1, 00